Biotech Stocks Facing FDA Decision In January 2025 - Nasdaq
Jan 1, 2025 · The FDA decision on Datopotamab Deruxtecan, proposed for the treatment of patients with previously treated metastatic HR-positive, HER2-negative breast cancer, is due …
BIIB Secures FDA Nod for Monthly Maintenance Dosing of ... - Nasdaq
13 hours ago · Post the FDA approval, patients have the option to transition to a monthly maintenance dosing regimen of Leqembi after completing an 18-month course of biweekly …
Biotech Stocks Facing FDA Decision In September 2024 - Nasdaq
Sep 1, 2024 · The FDA is scheduled to determine whether or not to convert accelerated approval of Travere Therapeutics' Filspari to a traditional approval on September 5, 2024.
FDA Calendar and Recent FDA News - Benzinga
Benzinga's FDA calendar shows historical FDA data, upcoming dates that companies will be impacted by the FDA and ranges of dates.
Biotech Stocks Facing FDA Decision In November 2024
Oct 30, 2024 · The FDA decision on Autolus Therapeutics' Obe-cel, proposed for the treatment of patients with relapsed/refractory adult B-cell acute lymphoblastic leukemia, is expected on …
Biotech Stocks Facing FDA Decision In October 2024
Sep 30, 2024 · The FDA decision on Biofrontera's request to increase the maximally approved dosage of Ameluz from one to three tubes per treatment is expected on October 4, 2024.
FDA Calendar - BioPharmCatalyst
Comprehensive suite of tools for trading and investing in biotech stocks. FDA Calendar, PDUFA Date Calendar, Biotech Company Screener and Database and much more.
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance …
1 day ago · TOKYO and CAMBRIDGE, Mass., Jan. 26, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, …
Supernus Pharmaceuticals Announces FDA Approval for Updated ... - Nasdaq
14 hours ago · The FDA has approved an updated Qelbree label, adding new pharmacodynamic data and lactation information for ADHD treatment. Quiver AI Summary Supernus …
FDA Calendar, Fda Approval Calendar, FDA Drug Approval
With our Free FDA Calendar, track upcoming PDUFA dates, FDA approvals, biotech catalysts, clinical trials, and regulatory events. Updated daily, it offers investors insights into stock …